I'm really excited about $NUWE right now. With a small float and the upcoming presentation of new clinical evidence for their Aquadex therapy at a maj...
Read More
I'm really excited about $NUWE right now. With a small float and the upcoming presentation of new clinical evidence for their Aquadex therapy at a major conference, I see a real opportunity for a squeeze. Despite past highs and lows, I believe the market is underestimating this stock's potential for recovery.
I'm really bullish on FGEN given the upcoming approval for roxadustat in China, which could lead to significant revenue growth. Plus, with the stock c...
Read More
I'm really bullish on FGEN given the upcoming approval for roxadustat in China, which could lead to significant revenue growth. Plus, with the stock currently near $0.35, I see a solid opportunity for it to bounce back to $1. I'm planning to hold for a quick gain based on upcoming catalysts.
I just bought some shares of NNVC because I see huge growth potential in their advancements for nanotech treatments targeting Mpox. With the current p...
Read More
I just bought some shares of NNVC because I see huge growth potential in their advancements for nanotech treatments targeting Mpox. With the current price at $1.56, I believe we are in for a significant upswing as the company strengthens its market position.
I'm convinced that AILE will rebound significantly, especially with the positive response from the CEO and the exciting partnership with Exult Global....
Read More
I'm convinced that AILE will rebound significantly, especially with the positive response from the CEO and the exciting partnership with Exult Global. Given the bullish sentiment and the potential for a rise to previous price levels, this stock seems like a solid long-term play.
I see Generation Uranium as a solid play in the energy sector right now, especially with the growing demand for nuclear power and looming supply defic...
Read More
I see Generation Uranium as a solid play in the energy sector right now, especially with the growing demand for nuclear power and looming supply deficits. With their strategic location and plans for exploration in a hot market, I'm feeling bullish about holding shares and reaping the benefits as they capitalize on this opportunity.
I've been following INVO Bioscience, and they seem ready for a strong upswing. With an exciting merger on the table and the growing demand for afforda...
Read More
I've been following INVO Bioscience, and they seem ready for a strong upswing. With an exciting merger on the table and the growing demand for affordable IVF services, I feel confident investing in this stock for some nice returns.
I've just identified ASNS as a strong buy at the current price of $1.52. With multiple new contracts boosting revenue momentum and a solid earnings re...
Read More
I've just identified ASNS as a strong buy at the current price of $1.52. With multiple new contracts boosting revenue momentum and a solid earnings report, I believe this stock is headed for at least $3 in the near future, especially if their acquisition talks pan out positively.
I just got into LASE after seeing some optimistic takes from fellow investors. The growth potential seems solid, especially with their innovative appr...
Read More
I just got into LASE after seeing some optimistic takes from fellow investors. The growth potential seems solid, especially with their innovative approach to industrial cleaning using lasers. I think holding on to this for a while longer could pay off big time, given the recent performance.
I'm excited about $OSTX as it's just 11% away from its all-time high of $4.60. If it breaks through that level, I believe we could see a strong uptren...
Read More
I'm excited about $OSTX as it's just 11% away from its all-time high of $4.60. If it breaks through that level, I believe we could see a strong uptrend without any resistance to hold it back, potentially leading to significant gains in the coming weeks.
I'm really bullish on HOVR right now, especially with the recent support levels and the potential for higher targets. The military partnerships and su...
Read More
I'm really bullish on HOVR right now, especially with the recent support levels and the potential for higher targets. The military partnerships and successful prototype tests create a strong case for growth. I'm eyeing the breakout above $1.05 towards $1.14 and beyond.
I'm watching $PAUIF closely as it seems to be showing signs of reversing from a downtrend. If it breaks resistance around $1.20, we could see a nice m...
Read More
I'm watching $PAUIF closely as it seems to be showing signs of reversing from a downtrend. If it breaks resistance around $1.20, we could see a nice move toward $1.40. I'm looking to play this for a potential 20-33% gain over the coming weeks.
I just bought ASTS because I believe there’s a huge upside potential here. The buzz around it suggests that we could see a 20x to 50x increase in our ...
Read More
I just bought ASTS because I believe there’s a huge upside potential here. The buzz around it suggests that we could see a 20x to 50x increase in our investments, which is hard to ignore. Definitely worth considering for a swing play in this market.
I just added to my position in ELTP because the growth metrics are impressive and the revenue is expected to increase as they roll out more products. ...
Read More
I just added to my position in ELTP because the growth metrics are impressive and the revenue is expected to increase as they roll out more products. With a potential billion dollar market cap in two years, I see significant upside ahead.
I'm thinking of picking up some TANH shares since it's a penny stock with low volume and a potential to bounce back to $1.00. With such a limited floa...
Read More
I'm thinking of picking up some TANH shares since it's a penny stock with low volume and a potential to bounce back to $1.00. With such a limited float, it seems like a perfect time to buy and ride the upcoming wave back to value.
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw sign...
Read More
I'm bullish on INBS as its non-invasive drug testing technology is gaining traction, especially with FDA approval coming soon. The stock just saw significant volume and breakout potential around the 50 DMA, so I'm looking for a solid upside as it enters the US market.
I'm really bullish on APLD right now because I think the market is completely underestimating its potential, especially with Nvidia's backing. I'm con...
Read More
I'm really bullish on APLD right now because I think the market is completely underestimating its potential, especially with Nvidia's backing. I'm considering moving from options to shares, as I believe once investors catch on, this stock is going to explode.
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, an...
Read More
I just saw INBS closed at $1.58 with great volume and potential FDA approval on the horizon. The upcoming 10-Q is expected to show a revenue spike, and with the market cap under $5 million, I'm convinced this could have a strong week ahead.
I'm seeing great potential in FRGGF based on positive recommendations and their plans for growth in mining and marketing. With increasing interest on ...
Read More
I'm seeing great potential in FRGGF based on positive recommendations and their plans for growth in mining and marketing. With increasing interest on social media, this stock could surge, especially as they ramp up operations this year.
I believe that LiveOne is poised for growth after the recent price hikes for its membership plans. With the music streaming market expected to grow si...
Read More
I believe that LiveOne is poised for growth after the recent price hikes for its membership plans. With the music streaming market expected to grow significantly, LVO seems like a good investment as they continue to innovate and expand their offerings.
I'm optimistic about $MDAI's future, especially with its strong government support and upcoming catalysts that could significantly boost the share pri...
Read More
I'm optimistic about $MDAI's future, especially with its strong government support and upcoming catalysts that could significantly boost the share price. With a target of $3 by mid next year, it feels like a solid long-term investment given the company's current financial stability and potential growth prospects.